AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 113 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q1 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $2,131,000 | -41.8% | 412,191 | +7.1% | 0.00% | -100.0% |
Q4 2015 | $3,664,000 | +136.4% | 384,835 | +104.6% | 0.00% | – |
Q3 2015 | $1,550,000 | -87.6% | 188,101 | -75.5% | 0.00% | -100.0% |
Q2 2015 | $12,485,000 | +31.5% | 768,797 | +337.2% | 0.00% | +33.3% |
Q4 2014 | $9,496,000 | +42.2% | 175,859 | -9.9% | 0.00% | +50.0% |
Q3 2014 | $6,677,000 | – | 195,283 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 1,382,735 | $73,076,000 | 20.10% |
Redmile Group, LLC | 699,070 | $37,750,000 | 4.11% |
Ghost Tree Capital, LLC | 125,000 | $6,750,000 | 3.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,614,669 | $87,192,000 | 3.13% |
Green Owl Capital Management, LLC | 26,000 | $1,404,000 | 1.26% |
COWEN INC. | 248,674 | $13,428,000 | 1.06% |
RTW INVESTMENTS, LP | 50,000 | $2,700,000 | 1.00% |
Cormorant Asset Management, LP | 65,000 | $3,510,000 | 0.54% |
Tourbillon Capital Partners, L.P. | 330,000 | $17,820,000 | 0.48% |
QVT Financial LP | 108,000 | $5,832,000 | 0.29% |